Key Points to Consider When Evaluating Andexxa for Formulary Addition.

Authors

Harry Peled, Pharmacy and Therapeutics Committee Chair, St. Jude Medical Center, 101 Val Mesa Drive, Fullerton, CA, 92835, USA
Nhu Quyen Dau
Helen Lau, Southern California Regional Clinical Quality and Risk Manager, Providence St. Joseph Health, Irvine, CA, USA

Document Type

Article

Publication Date

10-22-2019

Publication Title

Neurocrit Care

Department

Pharmacy

Recommended Citation

Peled, Harry; Dau, Nhu Quyen; and Lau, Helen, "Key Points to Consider When Evaluating Andexxa for Formulary Addition." (2019). Articles, Abstracts, and Reports. 2342.
https://digitalcommons.providence.org/publications/2342